{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T04:05:49Z","timestamp":1749960349821,"version":"3.41.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:p>Encouraged by bacteremia clearance using antistaphylococcal beta-lactams plus carbapenem combination in adults with refractory methicillin-sensitive <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> infection, we present our experience with 2 preterm infants and review 1 previously published case. Noted successful bacteremia clearance in all 3 must be weighed against possible adverse effects associated with carbapenem use.<\/jats:p>","DOI":"10.1097\/inf.0000000000004155","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T20:01:28Z","timestamp":1699041688000},"page":"145-148","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cefazolin and Carbapenem Combination to Treat Persistent Methicillin-sensitive Staphylococcus aureus Bacteremia in Preterm Infants"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-1285","authenticated-orcid":false,"given":"Stefan H. F.","family":"Hagmann","sequence":"first","affiliation":[{"name":"From the Division of Pediatric Infectious Diseases, Baystate Children\u2019s Hospital, Springfield, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Hodle","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Baystate Health, Springfield, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Brennan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Baystate Health, Springfield, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Szczerba","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Baystate Health, Springfield, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid Y.","family":"Camelo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Children\u2019s Hospital of Georgia, Augusta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Beachy","sequence":"additional","affiliation":[{"name":"Division of Neonatal Medicine, Baystate Children\u2019s Hospital, Springfield, Massachusetts"},{"name":"Department of Pediatrics, University of Massachusetts Chan Medical School-Baystate Health, Springfield, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan R.","family":"Horton","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Baystate Health, Springfield, Massachusetts"},{"name":"Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamapediatrics.2015.2380","article-title":"Burden of invasive Staphylococcus aureus infections in hospitalized infants.","volume":"169","author":"Ericson","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"e20200134","DOI":"10.1542\/peds.2020-0134","article-title":"Clinical management of Staphylococcus aureus bacteremia in neonates, children, and adolescents.","volume":"146","author":"McMullan","year":"2020","journal-title":"Pediatrics"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e20170183","DOI":"10.1542\/peds.2017-0183","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in children.","volume":"139","author":"Hamdy","year":"2017","journal-title":"Pediatrics"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1128\/AAC.01192-16","article-title":"Cefazolin and ertapenem, a synergistic combination used to clear persistent Staphylococcus aureus bacteremia.","volume":"60","author":"Sakoulas","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciz995","article-title":"Cefazolin and ertapenem salvage therapy rapidly clears persistent methicillin-susceptible Staphylococcus aureus bacteremia.","volume":"71","author":"Ulloa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"dlab148","DOI":"10.1093\/jacamr\/dlab148","article-title":"Oxacillin plus ertapenem combination therapy leads to rapid blood culture clearance and positive outcomes among patients with persistent MSSA bacteraemia: a case series.","volume":"3","author":"El-Dalati","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1111\/jocs.16040","article-title":"Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: a case series.","volume":"36","author":"Cardenas-Alvarez","year":"2021","journal-title":"J Card Surg"},{"key":"R8-20250614","first-page":"547","article-title":"Clearance of persistent Staphylococcus aureus bacteremia in a preterm neonate with the use of combination cefazolin and ertapenem.","volume":"25","author":"Akers","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1542\/peds.2011-0966","article-title":"Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.","volume":"129","author":"Shane","year":"2012","journal-title":"Pediatrics"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/ciad357","article-title":"Antibiotic myths for the infectious diseases clinician.","volume":"77","author":"McCreary","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1179\/1973947813Y.0000000110","article-title":"Clinical pharmacology of carbapenems in neonates.","volume":"26","author":"Pacifici","year":"2014","journal-title":"J Chemother"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cmi.2014.08.003","article-title":"Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.","volume":"21","author":"Zusman","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jhin.2008.05.020","article-title":"Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review.","volume":"70","author":"Paez","year":"2008","journal-title":"J Hosp Infect"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1086\/598189","article-title":"Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies.","volume":"48","author":"Naber","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"e0216621","DOI":"10.1128\/aac.02166-21","article-title":"Is the success of cefazolin plus ertapenem in methicillin susceptible Staphylococcus aureus bacteremia based on release of interleukin-1 beta?","volume":"66","author":"Smelter","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"ofac159","DOI":"10.1093\/ofid\/ofac159","article-title":"Potent activity of ertapenem plus cefazolin within staphylococcal biofilms: a contributing factor in the treatment of methicillin-susceptible Staphylococcus aureus endocarditis.","volume":"9","author":"Gilbertie","year":"2022","journal-title":"Open Forum Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:02:51Z","timestamp":1749945771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004155","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2023,10,27]]}}}